Accelr8 Announces Collaboration Agreement with Promega
News Oct 18, 2005
Accelr8 Technology Corporation has announced the signing of an agreement with Promega Corporation regarding Accelr8's proprietary OptiChem® surface chemistry for use in microarraying slides.
The agreement will allow for exploration of techniques in microarray research using Accelr8 and Promega technologies.
According to David Howson, Accelr8's president, “This agreement represents another event for Accelr8 in licensing out our technology components in the microarraying space.”
“We're gratified that Promega evaluated the alternatives and chose OptiChem because of its performance advantages,” said Howson.
“We are also pleased to be associated with Promega because of their well-deserved reputation for excellence.”
Accelr8's OptiChem coatings are designed to provide performance advantages that help to make OptiChem-coated slides an enabling component of next generation microarrays.
The ongoing revenues from licensing occur in parallel with Accelr8's primary business focus in developing the BACcelr8r™ rapid bacterial analysis system.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE